Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis



Status:Recruiting
Conditions:Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:3/23/2019
Start Date:May 10, 2018
End Date:February 2021
Contact:Caroline O'Hara
Email:cohara@translate.bio
Phone:8572092450

Use our guide to learn which trials are right for you!

A Phase 1/2, Randomized, Double-Blinded, Placebo-Controlled, Combined Single and Multiple Ascending Dose Study Evaluating the Safety, Tolerability, and Biological Activity of MRT5005 Administered by Nebulization to Adult Subjects With Cystic Fibrosis

This Phase 1/2, first-in-human study will evaluate the safety and tolerability of single and
multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of
adult subjects with CF. This study will also assess the delivery of the drug to bronchial
epithelial cells following multiple doses of MRT5005, and will characterize its biological
activity by measuring changes in CFTR protein levels and CFTR chloride channel activity
post-treatment.


Inclusion Criteria:

- Confirmed diagnosis of CF as defined by all of the following:

- A sweat chloride value of ≥60 mmol/L by quantitative pilocarpine iontophoresis
(documented in the subject's medical record).

- Two CF disease-causing CFTR mutations in Class I or II (genotype confirmed at the
screening visit).

- Chronic sinopulmonary disease and/or gastrointestinal/nutritional abnormalities
consistent with CF disease.

- Clinically stable CF disease, as judged by the investigator.

- FEV1 ≥50% and ≤90% of the predicted normal for age, gender, and height at screening.

- Resting oxygen saturation ≥92% on room air (pulse oximetry).

Exclusion Criteria:

- An acute upper or lower respiratory infection, pulmonary exacerbation, clinically
significant episode of hemoptysis or change in chronic respiratory medications
(including antibiotics) for CF lung disease within 28 days prior to dosing with
investigational product on Day 1.

- Receiving treatment with ivacaftor monotherapy (KALYDECO).

- Subjects with a Class III, IV, or V CFTR gene mutation in at least 1 allele.

- Infection with highly virulent bacteria associated with accelerated decline in
pulmonary function and/or decreased survival (e.g., Burkholderia cenocepacia,
Burkholderia dolosa, Mycobacterium abscessus).

Treatment with ORKAMBI is not an exclusion for this study.
We found this trial at
15
sites
801 North 29th Street
Billings, Montana 59107
406-238-2500
Billings Clinic Based in Billings, Montana, Billings Clinic is a community-governed health care organization consisting...
?
mi
from
Billings, MT
Click here to add this to my saved trials
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
700 Childrens Drive
Columbus, Ohio 43205
(616) 722-2000
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Gainesville, Florida 32610
(352) 392-3261
University of Florida The University of Florida (UF) is a major, public, comprehensive, land-grant, research...
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
326 North Mills Avenue
Orlando, Florida 32803
?
mi
from
Orlando, FL
Click here to add this to my saved trials
22 Bramhall St
Portland, Maine 04102
(207) 662-0111
Maine Medical Center One of the country's consistently highest rated hospitals is right in your...
?
mi
from
Portland, ME
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cleveland, Ohio 44106
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
1400 Jackson St
Denver, Colorado 80206
(303) 388-4461
National Jewish Health National Jewish Health is known worldwide for treatment of patients with respiratory,...
?
mi
from
Denver, CO
Click here to add this to my saved trials
Indianapolis, Indiana
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Knoxville, Tennessee 37920
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Portland, Oregon 97227
?
mi
from
Portland, OR
Click here to add this to my saved trials
Richmond, Virginia 23298
(804) 828-0100
Virginia Commonwealth University Since our founding as a medical school in 1838, Virginia Commonwealth University...
?
mi
from
Richmond, VA
Click here to add this to my saved trials